New Partnership in the UK and Ireland

Helsinki – June 14, 2021 – MVision AI is excited to announce partnership with the UK and Ireland-based distributor, Xiel ltd. Xiel will be distributing MVision AI’s high-quality, segmentation services throughout the UK and Ireland region.

“I am delighted Xiel has officially partnered with MVision, a company leading the way in AI technology and one we have followed closely for a number of years. AI is a buzz word in our sector at the moment and we are very excited about working with MVision to integrate their leading technology into Radiotherapy departments in the UK and Ireland”, said Jack Knight, Managing Director, Xiel Ltd

This has a high impact on RT treatment because, according to Cancer Research UK, the time between the urgent referral and treatment process can take up to 62 days. Thanks to Xiel’s distribution of MVision AI’s segmentation software, oncologists will be able to receive consistent, cancer radiotherapy treatment planning. MVision’s cutting-edge, segmentation solutions can help improve the efficiency of cancer patient’s radiotherapy.

MVsion’s CEO and co-founder, Mahmudul Hasan, highlighted his delight in this new partnership, stating that, “We have been working on MVision’s state-of-the-art segmentation services for the last three years. A growing number of hospitals have incorporated our services into their radiation oncology departments. Radiation oncologists have found our solutions to be essential, while improving the speed of service to their patients. We look forward to doing the same for UK patients, as our breakthrough solution reaches the UK and Ireland with the help of Xiel.”

If you are interested in learning more about Xiel’s impactful distribution, check out their informative, company website and professional LinkedIn profile.

For more information on our services, contact MVision AI

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Email: info (at) mvision.ai

FOR MEDIA INQUIRES:

+358 40 500 7915; pr (at) mvision.ai

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

2.2.2024

World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172…

News

30.1.2024

How can AI-based auto-contouring improve the life of patients who need palliative radiation therapy?

Cancer is one of the leading causes of morbidity and death, worldwide. Approximately 18 million people are diagnosed with cancer each year and the number is expected to increase. Pain is experienced by two thirds of patients having advanced, metastatic or terminal disease (1). Other symptoms caused by compression on…

Articles

22.1.2024

MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases